Undervalued Stocks Based On Cash Flows

Results

135

24 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

135 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
DCOM
New
US$40.594.1%48.7%US$1.8bUS$43.801.327.3%2.5%Banks
INTR
New
US$5.440%-26.0%US$2.3bUS$9.381.221.9%2.0%Banks
HAWK
US$21.25-7.2%n/aUS$1.9bUS$37.8643367.763.3%n/aCapital Goods
RDDT
US$166.94-4.6%16.7%US$30.4bUS$224.9245.425.3%n/aMedia
PCOR
New
US$41.914.8%-38.2%US$5.8bUS$69.324.6115.1%n/aSoftware
WLTH
New
US$8.794.1%n/aUS$1.2bUS$13.003.585.6%n/aDiversified Financials
BLMN
New
US$8.9711.3%3.6%US$740.6mUS$8.6435.645.6%0%Consumer Services
TPC
US$79.532.0%69.8%US$4.3bUS$113.2553.649.6%0.3%Capital Goods
DLO
US$12.69-0.8%10.5%US$3.6bUS$17.3519.420.8%1.5%Diversified Financials
GPC
New
US$116.026.7%-3.7%US$15.6bUS$134.00265.740.5%3.7%Retail
BBT
New
US$31.335.8%25.0%US$2.6bUS$32.831.142.3%4.1%Banks
APP
US$477.081.6%42.9%US$149.8bUS$650.3040.922.0%n/aSoftware
COF
US$204.001.2%-3.3%US$126.2bUS$254.6748.742.3%1.6%Diversified Financials
GROY
US$2.81-2.1%27.7%US$681.9mUS$6.0036.4116.4%0%Materials
NTRA
New
US$261.9113.2%55.9%US$37.3bUS$262.6715.058.0%n/aPharmaceuticals & Biotech
SOLS
US$82.69-3.4%n/aUS$13.8bUS$90.5769.824.5%0.4%Materials
RYN
US$21.914.4%-0.9%US$6.6bUS$26.001.243.2%11.1%Real Estate
YOU
US$55.177.2%99.7%US$7.1bUS$62.0045.426.6%1.5%Software
MELI
US$1,675.102.4%-34.6%US$82.1bUS$2,216.9644.226.7%0%Retail
RHI
US$32.763.7%-20.7%US$3.0bUS$29.8925.425.7%7.2%Commercial Services
LITE
US$816.98-3.9%762.2%US$67.1bUS$1,111.29144.879.1%n/aTech
LOB
US$41.408.2%37.8%US$1.9bUS$42.751.626.0%0.3%Banks
FBK
US$55.894.0%23.1%US$2.9bUS$64.381.530.2%1.5%Banks
ALKT
New
US$16.4211.9%-44.8%US$1.7bUS$21.253.7106.0%n/aSoftware
Page 1 of 4